Table 1.
Group A, n (%) | Group B, n (%) | |
---|---|---|
Population | 194 | 198 |
Mean age | 36.2 | 37.4 |
Ethnicity | Caucasian 194 (100%) | Caucasian 198 (100%) |
Indication for surgery | ||
Idiopathic phimosis | 188 (96.9%) | 189 (95.4%) |
Lichen Sclerosus phimosis | 8 (3.1%) | 9 (4.5%) |
Cancer phimosis | 0 (0%) | 0 (0%) |
Co-morbidities | ||
No co-morbidities | 161 (83%) | 165 (83.3%) |
Controlled diabetes | 11 (5.7%) | 12 (6.1%) |
Hypertension | 12 (6.2%) | 13 (6.6%) |
Vasculopathy | 6 (3.1%) | 5 (2.5%) |
Metabolic disorders | 16 (8.2%) | 14 (7.1%) |
Therapies | ||
Oral diabetic therapy/insulin | 11 (5.7%) | 12 (6.1%) |
Antihypertensive therapy | 10 (5.6%) | 10 (5.1%) |
Antiplatelet/anticoagulant | 13 (6.7%) | 15 (7.6%) |
Metabolic therapies | 11 (5.7%) | 12 (6.1%) |
Alpha adrenergic therapy | 9 (4.6%) | 7 (3.5%) |
Previous urological surgeries | 7 (3.6%) | 8 (4%) |